7 completed, 1 not yet recruiting. 4 Phase 2, 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Completed 4 |
| Phase 3 | 3 | Completed 3 |
Follow VT-1161: new trials by email Literature Review of VT-1161 trials Research Report on VT-1161
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Oteseconazole in the Treatment of Adults With Vulvovaginal Candidiasis（VVC） Oteseconazole (VT-1161) 150mg capsule - Vulvovaginal Candidiasis | Not yet recruiting | Beijing Tsinghua Chang Gung Hospital | 3000 | 2025-08-10 | 2025-07-01 | |
| Study of Oral Oteseconazole (VT-1161) for Acute Yeast Infections in Patients With Recurrent Yeast Infections Oteseconazole (VT-1161) 150mg capsule, Fluconazole 150mg capsule, Placebo - Recurrent Vulvovaginal Candidiasis | Phase 3 | Completed | Mycovia Pharmaceuticals Inc. | 219 | 2019-03-13 | 2022-02-04 |
| A Study of Oral Oteseconazole (VT-1161) for the Treatment of Patients With Recurrent Vaginal Candidiasis (Yeast Infection) Oteseconazole (VT-1161), Placebo - Recurrent Vulvovaginal Candidiasis | Phase 3 | Completed | Mycovia Pharmaceuticals Inc. | 425 | 2018-08-23 | 2026-02-17 |
| A Study of Oral Oteseconazole for the Treatment of Patients With Recurrent Vaginal Candidiasis (Yeast Infection) Oteseconazole (VT-1161), Placebo - Recurrent Vulvovaginal Candidiasis | Phase 3 | Completed | Mycovia Pharmaceuticals Inc. | 438 | 2018-08-16 | 2026-02-17 |
| A Study to Evaluate the Efficacy and Safety of Oral VT-1161 in Patients With Onychomycosis of the Toenail VT-1161, Placebo - Onychomycosis | Phase 2 | Completed | Viamet | 259 | 2015-02-17 | 2020-11-04 |
| A Study to Evaluate Oral VT-1161 in the Treatment of Patients With Recurrent Vaginal Candidiasis (Yeast Infection) VT-1161, Placebo - Recurrent Vulvovaginal Candidiasis | Phase 2 | Completed | Viamet | 254 | 2015-02-10 | 2019-10-15 |
| A Study to Evaluate the Efficacy and Safety of Oral VT-1161 in Patients With Moderate - Severe Interdigital Tinea Pedis VT-1161, placebo - Tinea Pedis | Phase 2 | Completed | Viamet | 50 | 2013-08-01 | 2018-08-01 |
| A Study to Evaluate the Efficacy and Safety of Oral VT-1161 in Patients With Acute Vaginal Candidiasis (Yeast Infection) VT-1161, Fluconazole - Candidiasis, Vulvovaginal | Phase 2 | Completed | Viamet | 55 | 2013-08-01 | 2018-08-01 |
Candidiasis, Vulvovaginal (6) · Onychomycosis (1) · Tinea Pedis (1)
Viamet (4) · Mycovia Pharmaceuticals Inc. (3) · Beijing Tsinghua Chang Gung Hospital (1)
United States (7)
PMID 36396498, PMID 38319878, PMID 29534874, PMID 32421854, PMID 32818963